CG Oncology, Inc. (CGON)
(Delayed Data from NSDQ)
$31.33 USD
-1.74 (-5.26%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $31.30 -0.03 (-0.10%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Price, Consensus and EPS Surprise
CGON 31.33 -1.74(-5.26%)
Will CGON be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CGON based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CGON
How to Find Up-and-Coming Stocks to Buy Right Now
CGON: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for CGON
Wall Street Breakfast: The Week Ahead
A Closer Look at 9 Analyst Recommendations For CG Oncology
CG Oncology initiated with Buy on bladder cancer potential at BofA
CG Oncology initiated with bullish view at BofA